Vivos Therapeutics Inc
NASDAQ:VVOS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
US |
|
Surrozen Inc
NASDAQ:SRZN
|
US |
|
Q
|
QL Resources Bhd
KLSE:QL
|
MY |
|
Turquoise Hill Resources Ltd
TSX:TRQ
|
CA |
|
C
|
Camsing Healthcare Ltd
SGX:BAC
|
SG |
|
Unozawa-gumi Iron Works Ltd
TSE:6396
|
JP |
|
B
|
Berling SA
WSE:BRG
|
PL |
|
F
|
Fermi Inc
NASDAQ:FRMI
|
US |
|
I
|
Innoprise Plantations Bhd
KLSE:INNO
|
MY |
|
Bank of N T Butterfield & Son Ltd
NYSE:NTB
|
BM |
|
A
|
Adecoagro SA
F:ACD
|
LU |
|
Vox Royalty Corp
XTSX:VOX
|
CA |
|
DP Eurasia NV
LSE:DPEU
|
NL |
|
Abdullah Saad Mohammed Abo Moati for Bookstores Company SJSC
SAU:4191
|
SA |
|
J
|
Jastech Ltd
KOSDAQ:090470
|
KR |
|
Towa Pharmaceutical Co Ltd
TSE:4553
|
JP |
|
E
|
Ensurge Micropower ASA
OSE:ENSU
|
NO |
|
P
|
Precision Drilling Corp
NYSE:PDS
|
CA |
Wall Street
Price Targets
VVOS Price Targets Summary
Vivos Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VVOS
is 5.1 USD
with a low forecast of 2.53 USD and a high forecast of 7.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VVOS's stock price target?
Price Target
5.1
USD
According to Wall Street analysts, the average 1-year price target for
VVOS
is 5.1 USD
with a low forecast of 2.53 USD and a high forecast of 7.35 USD.
What is Vivos Therapeutics Inc's Revenue forecast?
Projected CAGR
40%
For the last 5 years the
compound annual growth rate for
Vivos Therapeutics Inc's revenue is
6%.
The projected
CAGR
for the next 2 years is
40%.
